(17β)-4,17-Dimethyl-androsta-2,4-dieno[2,3-d]isoxazol-17-ol

(17β)-4,17-Dimethyl-androsta-2,4-dieno[2,3-d]isoxazol-17-ol, also known as DMADI, is a synthetic anabolic-androgenic steroid (AAS) that is commonly used in bodybuilding and sports to enhance muscle growth and performance. It was first developed in the late 1960s and has since been banned by most sports organizations due to its performance-enhancing effects. DMADI is a derivative of testosterone that has been modified to increase its anabolic activity while reducing its androgenic effects. It works by binding to androgen receptors in muscle tissue, promoting protein synthesis and increasing muscle mass. It also has the ability to increase red blood cell production, which can improve endurance and reduce fatigue during intense physical activity. In terms of chemical information, DMADI has a molecular weight of 318.47 g/mol and a molecular formula of C20H26N2O2.